Skip to main content
. 2026 Apr 24;27(1):155. doi: 10.1186/s10194-026-02370-7

Table 4.

Distribution of acute treatment responses according to Demographic and clinical characteristics

Characteristics Headache
Attacks, N
Acute Treatment Success Acute Treatment Failure Odds ratio (95% CI)
Pain freedom or relief within 1 hour Pain freedom or relief within 2 hours Pain freedom or relief within 4 hours No Effect Crude Adjusted
Age group
 10s 1,317 305 (23.2) 194 (14.7) 797 (60.5) 21 (1.6) 1.73 (1.55–1.94) 0.53 (0.45–0.62)
 20s 13,074 4,455 (34.1) 2,982 (22.8) 5,515 (42.2) 122 (0.9) 0.80 (0.77–0.84) 0.75 (0.71–0.78)
 30s 29,341 9,233 (31.5) 6,367 (21.7) 13,300 (45.3) 441 (1.5) 0.93 (0.90–0.96) 1.00 (0.97–1.03)
 40s 31,407 10,754 (34.2) 5,383 (17.1) 14,990 (47.7) 280 (0.9) (reference) (reference)
 50s 17,647 7,443 (42.2) 2,832 (16.0) 7,220 (40.9) 152 (0.9) 0.76 (0.73–0.79) 0.87 (0.84–0.91)
 60s+ 2,532 653 (25.8) 650 (25.7) 1,214 (47.9) 15 (0.6) 1.00 (0.92–1.08) 1.02 (0.94–1.11)
Sex
 Male 13,410 4,118 (30.7) 2,938 (21.9) 6,270 (46.8) 84 (0.6) (reference) (reference)
 Female 83,612 29,085 (34.8) 15,858 (19.0) 37,704 (45.1) 965 (1.2) 0.96 (0.92–1.00) 0.92 (0.89–0.96)
Headache intensity
 Mild 26,267 9,163 (34.9) 5,233 (19.9) 11,755 (44.8) 116 (0.4) (reference) (reference)
 Moderate 42,342 14,173 (33.5) 8,258 (19.5) 19,514 (46.1) 397 (0.9) 1.08 (1.04–1.11) 1.07 (1.04–1.11)
 Severe 28,133 9,853 (35.0) 5,305 (18.9) 12,442 (44.2) 533 (1.9) 1.04 (1.00–1.07) 0.98 (0.94–1.02)
Premonitory symptoms 54,461 18,689 (34.3) 11,115 (20.4) 24,052 (44.2) 605 (1.1) 0.91 (0.89–0.94) 0.97 (0.94–0.99)
Aura 7,002 2,917 (41.7) 1,226 (17.5) 2,758 (39.4) 101 (1.4) 0.79 (0.75–0.83) 0.78 (0.74–0.83)
Potential triggers 69,841 24,480 (35.1) 13,390 (19.2) 31,152 (44.6) 819 (1.2) 0.93 (0.91–0.96) 0.96 (0.93–0.99)
Type of treatment
 Triptans 86,301 32,928 (38.2) 18,608 (21.6) 33,804 (39.2) 961 (1.1) (reference) (reference)
 Other than triptans 10,441 261 (2.5) 188 (1.8) 9907 (94.9) 85 (0.8)

32.99

(29.98–36.30)

47.87

(39.23–58.41)